Welcome to the latest edition of touchREVIEWS in Neurology!
This free-to-access issue is full of topical content on a range of important topics, including expert interviews, editorials and review articles exploring the latest Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, neurosurgery, neuroimmunology, neuromuscular disease and neuropathic pain.
We would like to take this opportunity to thank all who contributed towards this edition, in particular our authors, Editor-in-Chiefs, editorial board members and partners.
We are now welcoming submissions to our 2023/2024 editions. If you’re interested in submitting an article, please get in touch!
Enjoy and happy reading!
Foreword: touchREVIEWS in Neurology, Volume 19, Issue 1, 2023
Welcome to the latest edition of touchREVIEWS in Neurology, featuring a range of interviews, reviews and reports on some of the key recent developments in neurological disease. We open with three expert interviews with key members of the pan-European organisation, Alzheimer Europe on the topic of care for people with dementia. In the first, Owen […]
Dementia in Europe Yearbook 2022: Employment and Related Social Protection for People with Dementia and Their Carers
In an expert interview, Owen Miller, Policy Officer at Alzheimer Europe, Luxembourg, discusses the Dementia in Europe Yearbook 2022: Employment and Related Social Protection for People with Dementia and their Carers (henceforth, the Yearbook).1 The Yearbook is a report that provides an overview of the challenges and opportunities that people with dementia and their caregivers face in Europe. It is published by […]
Sex, Gender and Sexuality in the Context of Dementia: A Guide to Raise Awareness Amongst Health and Social Care Workers
The report entitled “Sex, gender and sexuality in the context of dementia: A guide to raise awareness amongst health and social care workers“ is a guide published by Alzheimer Europe that offers practical advice to health and social care workers on how to address issues related to sex, gender and sexuality in the context of dementia.1 The guide […]
Guidelines for the Ethical and Inclusive Communication About/Portrayal of Dementia and People with Dementia and People with Dementia
The Guidelines for the ethical and inclusive communication about portrayal of dementia and people with dementia were published by Alzheimer Europe and the European Working Group of People with Dementia (EWGPWD).1,2 The document provides guidance on how to communicate about dementia and people living with dementia ethically and inclusively. The guidelines emphasize the importance of respecting the rights and dignity of individuals with dementia and of avoiding stigmatizing […]
Wellness in Parkinson’s Disease: A Framework for Management Using a Holistic Culturally Sensitive Approach
In modern medicine, the concept of wellness is accompanied by many misconceptions. Adopting wellness as a treatment approach has been well defined and implemented in cardiovascular disease, diabetes and some types of cancer management but has not yet been widely applied to neurologic diseases.1–5 The commercialization of the wellness industry has led to the misconception of wellness as expensive and only accessible to a niche population […]
Lecanemab: The Price of a Breakthrough
After so many failures, we finally got the positive signal that we have been waiting for: a disease-modifying treatment that might work for Alzheimer’s disease (AD). On 6 January 2023, lecanemab, a humanized immunoglobulin G1 version of a mouse monoclonal antibody that selectively binds to large, soluble amyloid-beta (Aβ) protofibrils, was approved by the US […]
Exploring the Impact of Coronavirus Disease 2019 on Dementia: A Review
The novel severe acute respiratory syndrome coronavirus 2 has caused a worldwide pandemic, and its impact on healthcare systems around the world is still being investigated. The potential effect of coronavirus disease 2019 (COVID-19) on people living with dementia and the ability of COVID-19 to precipitate the risk of developing dementia are particular areas of concern. This article provides an overview of the current understanding of the impact […]
Proton Pump Inhibitor Use and Risk of Dementia in Older Adults: A Systematic Review
Gastroesophageal reflux disease (GERD) is a chronic condition affecting over 750 million people globally.1 The disease causes acid from the stomach to reflux into the oesophagus, leading to epigastric discomfort, cough, sore throat and chest pain.1 Left untreated, this disease can lead to oesophagitis, gastritis, oesophageal metaplasia, gastrointestinal ulcers, strictures and bleeding.2 For mild cases of acid disorders, […]
History of Frameless Radiosurgery
Intracranial radiosurgery, no matter the means or methods of administration, is predicated on a core set of principles, including head immobilization and precise delineation of the treatment target. For some five decades after Leksell introduced the concept of stereotactic radiosurgery in 1951,1 rigid head fixation via an invasive device was an integral component towards these ends. […]
Updates in Paediatric Acute Disseminated Encephalomyelitis and Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Acute disseminated encephalomyelitis (ADEM), first characterized in 1931,1 is a non-specific clinical syndrome of polyfocal central nervous system (CNS) inflammatory demyelination; it is characterized by encephalopathy and large, poorly demarcated cerebral white matter lesions.2,3 Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD), a specific neuronal antibody-mediated disease that can often present as ADEM, was discovered only in the last decade.4 Both […]
Patients’ Beliefs in Optimal Pain Management: A Pilot Study
Opioid therapy has become a mainstay for the treatment of chronic pain, despite evidence that these medications may be ineffective and even unsafe in this patient population.1,2 In patients with chronic back pain, the use of first-line medications (non-steroidal anti-inflammatory drugs and acetaminophen) declined by 48% from 1999 to 2010; simultaneously, there was a 53% rise […]
LGMDR1 with Prominent Limb–Joint Contractures and Inflammatory Changes Misdiagnosed as Scleromyositis with a Novel CAPN3 Mutation: A Case Report
Highlights Limb–joint contractures may represent an important clinical clue of muscle dystrophies, as they limit the spectrum of the diagnosis assumptions. Limb–girdle muscular dystrophies phenotype can rarely be a clinical presentation of retractile myopathies, except for non-specific Achilles tendon tightness. Anti-PM/Scl antibody screening using line-blot assays and commercial antibody–panel testing is likely to detect false-positive antibodies. Dysferlinopathies, calpainopathy and facioscapulohumeral muscular dystrophy are the conditions most frequently confused […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!